2020
DOI: 10.1016/j.cellsig.2020.109815
|View full text |Cite
|
Sign up to set email alerts
|

New insights in Hippo signalling alteration in human papillomavirus-related cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 187 publications
0
8
0
Order By: Relevance
“…Genotype-specific differences could also explain the stronger effect of TEADi on HPV18 E7 in lifespan extension assays ( Figure 6 ). Although other reports have suggested that HPV might activate YAP1 ( He et al, 2015 ; Morgan et al, 2020 ; Olmedo-Nieva et al, 2020 ; Webb Strickland et al, 2018 ), no specific activity of an HPV protein has previously been shown to enable YAP1 activation. Other groups have proposed that HPV E6 activates YAP1 ( He et al, 2015 ; Webb Strickland et al, 2018 ), and we observed modest YAP1 activation by HPV E6 compared to E7.…”
Section: Discussionmentioning
confidence: 90%
“…Genotype-specific differences could also explain the stronger effect of TEADi on HPV18 E7 in lifespan extension assays ( Figure 6 ). Although other reports have suggested that HPV might activate YAP1 ( He et al, 2015 ; Morgan et al, 2020 ; Olmedo-Nieva et al, 2020 ; Webb Strickland et al, 2018 ), no specific activity of an HPV protein has previously been shown to enable YAP1 activation. Other groups have proposed that HPV E6 activates YAP1 ( He et al, 2015 ; Webb Strickland et al, 2018 ), and we observed modest YAP1 activation by HPV E6 compared to E7.…”
Section: Discussionmentioning
confidence: 90%
“…Genotype-specific differences could also explain the stronger effect of TEADi on HPV18 E7 in lifespan extension assays (Figure 6). Although other reports have suggested that HPV might activate YAP1 (He et al, 2015;Morgan et al, 2020;Olmedo-Nieva et al, 2020;Webb Strickland et al, 2018), no specific activity of an HPV protein has previously been shown to enable YAP1 activation. Other groups have proposed that HPV E6 activates YAP1 (He et al, 2015;Webb Strickland et al, 2018), but we did not observe YAP1 activation by HPV E6.…”
Section: Discussionmentioning
confidence: 90%
“…Currently, Hippo signalling has emerged as one of the key pathways being altered frequently in HPV-related cancers (Olmedo-Nieva et al, 2020). It has been suggested that high-risk E6 requires the PDZ motif to promote YAP nuclear localisation in serum-starved keratinocytes (Webb Strickland et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…Previous literature has indicated that E6 protein as a homeostasis regulator during productive infection, and in both the high and low-risk Alpha types, can regulate p53 and thus indirectly Notch-mediated epithelial differentiation (Khelil et al, 2021; Kranjec et al, 2017; Murakami et al, 2019; Yugawa et al, 2007). Moreover, accumulating evidence suggests that E6 modulates epithelial homeostasis through interacting with key molecules involved in WNT, NOTCH and HIPPO signalling (Gupta et al, 2018; Lichtig et al, 2010; Olmedo-Nieva et al, 2020; Sominsky et al, 2014). There is increasing evidence that the HIPPO pathway effector yes-associated protein (YAP) plays pivotal role in controlling epidermal homeostasis and high-risk E6 has been shown to control YAP nucleus-cytoplasm shift to activate YAP transcriptional activity (He et al, 2015; Webb Strickland et al, 2018).…”
Section: Introductionmentioning
confidence: 99%